WUN Wins Competitive PATH Award

Registration is OPEN for our first WUN Narcolepsy Webinar: Kansas City Education Day Re-Imagined on July 18, 2020

American Sleep Apnea Association is hosting its AWAKEtogether Summit virtually!

Avadel Pharmaceuticals Announces Positive Topline Results from its Pivotal Phase 3 REST-ON Trial of Once-Nightly FT218 for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients with Narcolepsy

WUN’s Narcolepsy Family Summer Camp – Cancelled

Narcolepsy Interview & Survey Opportunity

NORD Launches Financial Assistance Program for Rare Disease Community Members Impacted by COVID-19

Focus Group Participants Needed to Develop a Pediatric Narcolepsy Patient Reported Outcomes Scale (PN-PROS)

Avadel Pharmaceuticals Completes the REST-ON Phase 3 Pivotal Trial of FT218 for Excessive Daytime Sleepiness and Cataplexy in Patients with Narcolepsy

Doing Life During COVID-19 Pandemic